Where is zhifei Bio-COVID-19 Vaccine? -Where's the reservation?

In Dongguan, you need to make an appointment in advance if you want to get zhifei biological COVID-19 vaccine. In fact, different community hospitals have different appointment methods. Can be used as a reference. The following are the detailed appointment methods and notification methods.

How to make an appointment for zhifei Bio-COVID-19 vaccine? The vaccination target of zhifei recombinant COVID-19 vaccine is1population aged 8 years and above. Can not be mixed with inactivated vaccine and adenovirus vector vaccine!

See the following table for the appointment methods of towns and districts in Dongguan:

Tips:

Due to the limited stock of vaccines in COVID-19, zhifei, Anhui Province, all towns and streets (parks) make an appointment for vaccination while stocks last!

If you have any questions, you can call the special class for vaccine use:

Who can get zhifei vaccine in Dongguan?

Due to the limited stock of COVID-19 vaccine in zhifei, Anhui Province in Dongguan, in order to meet the needs of the masses, only citizens who have received at least 1 dose of COVID-19 vaccine in zhifei, Anhui Province are allowed to receive the second and third doses of vaccine.

Inoculate 3 times in the whole process. The interval between two adjacent doses is recommended to be ≥4 weeks. The second dose should be completed within 8 weeks after 1 dose, and the third dose should be completed within 6 months after 1 dose. Intramuscular injection of deltoid muscle of upper arm.

These people can't be vaccinated:

1. People who are known to be allergic to any component of the vaccine (including auxiliary materials);

2. Suffering from acute disease, serious chronic disease, acute attack of chronic disease and fever;

3. Pregnant women;

4. People with uncontrollable epilepsy and other progressive nervous system diseases.

The recombinant subunit vaccine approved for emergency use in China is the recombinant COVID-19 vaccine (CHO cell) produced by Anhui Zhifeilong Kyle Biopharmaceutical Co., Ltd. (Zhifeilong Kyle). Its technical principle is similar to that of mature hepatitis B CHO cell vaccine: novel coronavirus s protein receptor binding region (RBD) gene is recombined into China hamster ovary (CHO) cell gene, expressed in vitro to form RBD dimer, and added with aluminum hydroxide adjuvant to improve immunogenicity, and injected into human body to induce human body to produce neutralizing antibody, thus achieving the purpose of preventing infection.

Inoculated population

At present, the vaccination target is1people aged 8 and above.

Immune program

Inoculate 3 doses; The interval between two adjacent doses is recommended to be ≥4 weeks. The second dose should be completed within 8 weeks after 1 dose, and the third dose should be completed within 6 months after 1 dose.